官方网站:http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/#description
投稿网址:https://www.evise.com/evise/faces/pages/navigation/NavController.jspx?
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1094-5539%5BISSN%5D
肺部药理学和治疗学(以前称为肺部药理学)涉及从分子到临床方面的肺药理学。主题包括肺的主要疾病,包括哮喘、囊性纤维化、肺循环、ARDS、癌症、支气管炎、脓胸和药物输送。 将考虑对人和动物进行实验室和临床研究,包括与癌症,肺结核和感染的化疗有关的研究。 除了原始研究论文,该期刊还将包括评论文章和书评。
Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphesyma and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 3区 | PHARMACOLOGY & PHARMACY 药学 RESPIRATORY SYSTEM 呼吸系统 | 3区 3区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q3 | PHARMACOLOGY & PHARMACY | Q3 | 3.282 |
RESPIRATORY SYSTEM | Q3 |
* 请认真填写需求信息,学术顾问24小时内与您取得联系。